Friday, July 31, 2009

Medical News

Medical News


Post-PCI bleeding increased in triple therapy patients

Posted: 30 Jul 2009 05:00 PM PDT

Adding dual antiplatelet therapy to pre-existing oral anticoagulant therapy increases bleeding after percutaneous coronary intervention, French study results show.

Encouragement fails to boost activity levels post-stroke

Posted: 30 Jul 2009 05:00 PM PDT

Repeatedly encouraging stroke patients to exercise has little impact on long-term levels of physical activity, a randomized controlled trial has shown.

MRI helps psoriatic arthritis treatment decision making

Posted: 30 Jul 2009 05:00 PM PDT

A whole-body magnetic resonance imaging scan in patients with psoriatic arthritis can provide more relevant information than a clinical exam alone, research shows.

Prevalence of coeliac disease increased in psoriasis patients

Posted: 30 Jul 2009 05:00 PM PDT

The prevalence of coeliac disease is significantly higher in individuals with psoriasis than in healthy controls, research shows.

Streptococcal DNA triggers immune reaction in psoriasis

Posted: 30 Jul 2009 05:00 PM PDT

Streptococcal antigen lacking nucleic acid decreases the proliferation of peripheral blood mononuclear cells and the activation of T cells in psoriasis patients, research shows.

PAP vaccine shows recurrent prostate cancer treatment promise

Posted: 30 Jul 2009 05:00 PM PDT

A DNA vaccine encoding prostatic acid phosphatase elicits an antigen-specific T cell response and may offer a promising treatment for stage D0 prostate cancer, the results of a US study indicate.

High-dose radiotherapy improves prostate cancer control in all patients

Posted: 30 Jul 2009 05:00 PM PDT

High-dose radiotherapy offers better protection against prostate cancer biochemical recurrence than conventional-dose radiotherapy, regardless of risk status, conclude Brazilian scientists.

Computational modeling holds promise of personalized therapy

Posted: 30 Jul 2009 05:00 PM PDT

A systems biology approach is able to predict resistance to targeted breast cancer therapies such as trastuzumab, study results suggest.

PAP vaccine shows recurrent prostate cancer treatment promise

Posted: 30 Jul 2009 05:00 PM PDT

A DNA vaccine encoding prostatic acid phosphatase elicits an antigen-specific T cell response and may offer a promising treatment for stage D0 prostate cancer, the results of a US study indicate.

High-dose radiotherapy improves prostate cancer control in all patients

Posted: 30 Jul 2009 05:00 PM PDT

High-dose radiotherapy offers better protection against prostate cancer biochemical recurrence than conventional-dose radiotherapy, regardless of risk status, conclude Brazilian scientists.

Autoantibodies contribute to some type V hyperlipoproteinemia cases

Posted: 30 Jul 2009 05:00 PM PDT

A small proportion of sporadic type V hyperlipoproteinemia cases may be caused by auto-antibodies inhibiting the activity of lipoprotein lipase, say researchers.

Berry extract improves lipid profile in patients with dyslipidemia

Posted: 30 Jul 2009 05:00 PM PDT

A study in a middle-aged Chinese population has shown that taking a dietary supplement of pure anthocyanin extracted from berries significantly improved their lipid profiles.

Renin gene variant and diabetes influence efficacy of valsartan treatment

Posted: 30 Jul 2009 05:00 PM PDT

Study results show that a variant of the renin gene and diabetic status influence the blood-pressure lowering efficacy of the angiotensin receptor blocker valsartan.

Young with Type 1 diabetes, low vitamin C at risk for subclinical CVD

Posted: 30 Jul 2009 05:00 PM PDT

Low plasma concentrations of vitamin C are associated with adverse changes in the microcirculation, peripheral arteries, and ventricular repolarization in young people with Type 1 diabetes, Swedish researchers report.

Publishing UK surgical mortality rates ‘improved patient outcomes’

Posted: 30 Jul 2009 05:00 PM PDT

The decision to publish national mortality rates in UK cardiac surgery has been hailed as a success, with a new report showing that death rates fell despite an increase in the age of patients and the complexity of their conditions.

Efforts needed to reduce early hazard post-PCI

Posted: 30 Jul 2009 05:00 PM PDT

A study of survival among patients undergoing angioplasty for different manifestations of coronary artery disease has found that patients with ST-elevation myocardial infarction have the greatest risk for death in the first 6 months post-event.

Computational modeling holds promise of personalized therapy

Posted: 30 Jul 2009 05:00 PM PDT

A systems biology approach is able to predict resistance to targeted breast cancer therapies such as trastuzumab, study results suggest.

No comments:

Post a Comment